Efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study

被引：0
|
作者：
Ebrecht, M.
Sickmann, V
Kungel, M.
Werner, C.
Marcus, R.
McQuade, R.
Modell, S.
机构：
[1] Bristol Myers Squibb Co, Munich, Germany
[2] Otsuka Pharma GmbH, Frankfurt, Germany
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[4] Otsuka Amer Pharmaceut Inc, Princeton, NJ USA
来源：
PHARMACOPSYCHIATRY | 2007年 / 40卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：207 / 207
页数：1
相关论文
共 50 条
  • [1] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study
    Berman, Robert M.
    Marcus, Ronald N.
    Swanink, Rene
    McQuade, Robert D.
    Carson, William H.
    Corey-Lisle, Patricia K.
    Khan, Arif
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (06) : 843 - 853
  • [2] The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder - A second multicenter, randomized, double-blind, placebo-controlled study
    Marcus, Ronald N.
    McQuade, Robert D.
    Carson, William H.
    Hennicken, Delphine
    Fava, Maurizio
    Simon, Jeffrey S.
    Trivedi, Madhukar H.
    Thase, Michael E.
    Berman, Robert M.
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 156 - 165
  • [3] Efficacy and Safety of Cariprazine as Adjunctive Therapy in Major Depressive Disorder: A Double-blind, Placebo-controlled Study
    Fava, Maurizio
    Durgam, Suresh
    Mergel, Victor
    Earley, Willie
    Nemeth, Gyoergy
    Laszlovszky, Istvan
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S352 - S353
  • [4] Efficacy and safety of tipepidine as adjunctive therapy in major depressive disorder: A randomized, double-blind, placebo-controlled clinical trial
    Hoobehfekr, Saba
    Moghaddam, Hossein Sanjari
    Shalbafan, Mohammadreza
    Hashemi, Maryam Ghazizadeh
    Pirmoradi, Mohammad Mehdi
    Sakenian, Amirhossein
    Poopak, Amirhossein
    Kashefinejad, Shayan
    Yarahmadi, Masoomeh
    Akhondzadeh, Shahin
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2021, 75 (02) : 57 - 62
  • [5] The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study
    Wang, Xiaoliang
    Fan, Yimin
    Li, Guanjun
    Li, Huafang
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2021, 36 (03) : 133 - 139
  • [6] Palmitoylethanolamide as adjunctive therapy in major depressive disorder: A double-blind, randomized and placebo-controlled trial
    Ghazizadeh-Hashemi, Maryam
    Ghajar, Alireza
    Shalbafan, Mohammad-Reza
    Ghazizadeh-Hashemi, Fatemeh
    Afarideh, Mohsen
    Malekpour, Farzaneh
    Ghaleiha, Ali
    Ardebili, Mehrdad Eftekhar
    Akhondzadeh, Shahin
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 127 - 133
  • [7] Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Ryou, Jae Hyun
    Chung, Sung Ah
    Kim, Na Yeon
    Hwang, Hyunchan
    Kim, Hye Ri
    Kim, Hee Jin
    Han, Doug Hyun
    Kim, Sun Mi
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2022, 91 (SUPPL 1) : 34 - 34
  • [8] Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Ryou, Jae Hyun
    Chung, Sung Ah
    Kim, Na Yeon
    Hwang, Hyunchan
    Kim, Hye Ri
    Kim, Hee Jin
    Han, Doug Hyun
    Kim, Sun Mi
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2022, 91 : 34 - 34
  • [9] Efficacy of aripiprazole as adjunctive therapy in major depressive disorder with somatic symptoms: A randomized, double-blind, placebo-controlled trial with clinical and electroencephalography evidence
    Kim, Hee Jin
    Han, Doug Hyun
    Choi, Kang Ta
    Hwang, Hyun Chan
    Min, Kyoung Joon
    Kim, Sun Mi
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2023, 37 (03) : 289 - 302
  • [10] Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zajecka, John
    Schatzberg, Alan
    Stahl, Stephen
    Shah, Amy
    Caputo, Angelika
    Post, Anke
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (02) : 135 - 144
12345